Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial.
Arpa
Javier
J
Sanz-Gallego
Irene
I
Medina-Báez
Josmarlin
J
Portela
Luis Valmor Cruz
LV
Jardim
Laura Bannach
LB
Torres-Aleman
Ignacio
I
Saute
Jonas Alex Morales
JA
D000328:Adult; D000704:Analysis of Variance; D006801:Humans; D007279:Injections, Subcutaneous; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D020754:Spinocerebellar Ataxias / Q000188:drug therapy*; D016896:Treatment Outcome
D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I